Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Muram

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Current Medical Research and Opinion|November 2, 2006
Duloxetine in the treatment of women with stress urinary incontinence: results from DESIRE (Duloxetine Efficacy and Safety for Incontinence in Racial and Ethnic populations)David L Weinstein, Jay S Cohen, Chaofeng Liu, et al.
American Journal of Men'S Health|October 2, 2014
Retrospective Analysis of Dose Titration and Serum Testosterone Level Assessments in Patients Treated With Topical TestosteroneDavid Muram, Anna Kaltenboeck, Natalie Boytsov, et al.
RMD Open|October 27, 2017
Safety and efficacy of baricitinib in elderly patients with rheumatoid arthritisRoy Fleischmann, Jahangir Alam, Vipin Arora, et al.
Current Medical Research and Opinion|September 17, 2010
Patient characteristics and utilization of breast cancer screening or diagnostic procedures prior to initiation of raloxifene, bisphosphonates and calcitoninShonda A Foster, Albert Whangbo, Beth Mitchell, et al.
Current Medical Research and Opinion|September 12, 2015
Measurement of testosterone: how important is a morning blood draw?E David Crawford, Wendy Poage, Allen Nyhuis, et al.
Rheumatology and Therapy|October 26, 2018
Safety and Efficacy of Baricitinib in Patients Receiving Conventional Synthetic Disease-Modifying Antirheumatic Drugs or CorticosteroidsRonald van Vollenhoven, Cameron Helt, Vipin Arora, et al.
Menopause (New York, N.Y.)|February 23, 2007
The effects of combined raloxifene and oral estrogen on vasomotor symptoms and endometrial safetyDale W Stovall, Wulf H Utian, Margery L S Gass, et al.
Menopause (New York, N.Y.)|October 14, 2011
Gynecologic effects of arzoxifene in postmenopausal women with osteoporosis or low bone massSteven R Goldstein, Harjit Pal Bhattoa, Patrick Neven, et al.
Obstetrics and Gynecology|October 4, 2005
Validation of a two-item quantitative questionnaire for the triage of women with urinary incontinenceAlfred E Bent, Angelo E Gousse, Susan L Hendrix, et al.
Neurourology and Urodynamics|June 21, 2007
Duloxetine compared with placebo for the treatment of women with mixed urinary incontinenceAlfred E Bent, Angelo E Gousse, Susan L Hendrix, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Current Medical Research and Opinion|November 2, 2006
Duloxetine in the treatment of women with stress urinary incontinence: results from DESIRE (Duloxetine Efficacy and Safety for Incontinence in Racial and Ethnic populations)David L Weinstein, Jay S Cohen, Chaofeng Liu, et al.
American Journal of Men'S Health|October 2, 2014
Retrospective Analysis of Dose Titration and Serum Testosterone Level Assessments in Patients Treated With Topical TestosteroneDavid Muram, Anna Kaltenboeck, Natalie Boytsov, et al.
RMD Open|October 27, 2017
Safety and efficacy of baricitinib in elderly patients with rheumatoid arthritisRoy Fleischmann, Jahangir Alam, Vipin Arora, et al.
Current Medical Research and Opinion|September 17, 2010
Patient characteristics and utilization of breast cancer screening or diagnostic procedures prior to initiation of raloxifene, bisphosphonates and calcitoninShonda A Foster, Albert Whangbo, Beth Mitchell, et al.
Current Medical Research and Opinion|September 12, 2015
Measurement of testosterone: how important is a morning blood draw?E David Crawford, Wendy Poage, Allen Nyhuis, et al.
Rheumatology and Therapy|October 26, 2018
Safety and Efficacy of Baricitinib in Patients Receiving Conventional Synthetic Disease-Modifying Antirheumatic Drugs or CorticosteroidsRonald van Vollenhoven, Cameron Helt, Vipin Arora, et al.
Menopause (New York, N.Y.)|February 23, 2007
The effects of combined raloxifene and oral estrogen on vasomotor symptoms and endometrial safetyDale W Stovall, Wulf H Utian, Margery L S Gass, et al.
Menopause (New York, N.Y.)|October 14, 2011
Gynecologic effects of arzoxifene in postmenopausal women with osteoporosis or low bone massSteven R Goldstein, Harjit Pal Bhattoa, Patrick Neven, et al.
Obstetrics and Gynecology|October 4, 2005
Validation of a two-item quantitative questionnaire for the triage of women with urinary incontinenceAlfred E Bent, Angelo E Gousse, Susan L Hendrix, et al.
Neurourology and Urodynamics|June 21, 2007
Duloxetine compared with placebo for the treatment of women with mixed urinary incontinenceAlfred E Bent, Angelo E Gousse, Susan L Hendrix, et al.
Pageof 4